BioCentury | Aug 31, 2017
Product R&D

Cutting through resistance

...wins on efficacy and avoiding resistance. At least three companies -- AmpliPhi Biosciences Corp. , Intralytix Inc....
...CO. (NYSE:DD), Wilmington, Del. Eligo Bioscience S.A.S., Paris, France Intellia Therapeutics Inc. (NASDAQ:NTLA), Cambridge, Mass. Intralytix Inc....
BioCentury | Feb 23, 2017
Tools & Techniques

Showdown: bacteria vs. virus

...raised $6 million in a series A round last year and subsequent undisclosed additional funding. Intralytix Inc....
...Russia and former Eastern bloc countries. Alexander Sulakvelidze, VP of R&D and chief scientist at Intralytix...
...their infection, said Salka. Other companies developing phage cocktails include Intralytix and Pherecydes Pharma S.A. Intralytix...
BioCentury | Jan 13, 2017
Company News

Ferring, Intralytix deal

...Ferring and Intralytix partnered to develop and commercialize bacteriophage therapies targeting microbiome dysbiosis of the female...
...initial focus will be on indications related to Clostridium difficile and vancomycin-resistant Enterococcus (VRE) infections. Intralytix...
...Pharmaceuticals A/S , Saint-Prex, Switzerland Intralytix Inc. , Baltimore, Md. Business: Dermatology, Genitourinary, Other Alex Himes Ferring Pharmaceuticals A/S Intralytix Inc....
BioCentury | Apr 28, 2016
Finance

Public-Private Partnership Roundup

...pathology toward the goal of developing new therapeutics. In July, Ferring announced a deal with Intralytix Inc....
...Association, Berlin, Germany Illumina Inc. (NASDAQ:ILMN), San Diego, Calif. Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Cambridge, Mass. Intralytix Inc....
BioCentury | Aug 24, 2015
Company News

Ferring, Intralytix deal

...Intralytix will assist Ferring in producing and manufacturing the bacteriophages for use in clinical trials. Intralytix...
...to begin next year. Ferring will have the option to license and market the bacteriophages. Intralytix...
...not disclosed, and Ferring did not respond to inquiries. Ferring Pharmaceuticals A/S , Saint-Prex, Switzerland Intralytix Inc....
BioCentury | Aug 15, 2013
Cover Story

B cell lymphoma and the microbiome

...can be freeze-dried and turned into pills without losing efficiency, and phage-based products such as Intralytix Inc....
...monocytogenes . SalmoFresh is a blend of phages that target and kill Salmonella enterica . Intralytix...
...Lou, K.-J. SciBX 6 (31); doi:10.1038/scibx.2013.812 Published online Aug. 15, 2013 Companies and Institutions Mentioned Intralytix Inc....
BioCentury | Sep 26, 2011
Company News

Intralytix, P&G deal

...The companies partnered to develop bacteriophage-based technology for multiple undisclosed applications. Details were not disclosed. Intralytix...
...monocytogenes on food products and EcoShield to reduce or eliminate Escherichia coli on red meat. Intralytix Inc....
Items per page:
1 - 7 of 7
BioCentury | Aug 31, 2017
Product R&D

Cutting through resistance

...wins on efficacy and avoiding resistance. At least three companies -- AmpliPhi Biosciences Corp. , Intralytix Inc....
...CO. (NYSE:DD), Wilmington, Del. Eligo Bioscience S.A.S., Paris, France Intellia Therapeutics Inc. (NASDAQ:NTLA), Cambridge, Mass. Intralytix Inc....
BioCentury | Feb 23, 2017
Tools & Techniques

Showdown: bacteria vs. virus

...raised $6 million in a series A round last year and subsequent undisclosed additional funding. Intralytix Inc....
...Russia and former Eastern bloc countries. Alexander Sulakvelidze, VP of R&D and chief scientist at Intralytix...
...their infection, said Salka. Other companies developing phage cocktails include Intralytix and Pherecydes Pharma S.A. Intralytix...
BioCentury | Jan 13, 2017
Company News

Ferring, Intralytix deal

...Ferring and Intralytix partnered to develop and commercialize bacteriophage therapies targeting microbiome dysbiosis of the female...
...initial focus will be on indications related to Clostridium difficile and vancomycin-resistant Enterococcus (VRE) infections. Intralytix...
...Pharmaceuticals A/S , Saint-Prex, Switzerland Intralytix Inc. , Baltimore, Md. Business: Dermatology, Genitourinary, Other Alex Himes Ferring Pharmaceuticals A/S Intralytix Inc....
BioCentury | Apr 28, 2016
Finance

Public-Private Partnership Roundup

...pathology toward the goal of developing new therapeutics. In July, Ferring announced a deal with Intralytix Inc....
...Association, Berlin, Germany Illumina Inc. (NASDAQ:ILMN), San Diego, Calif. Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Cambridge, Mass. Intralytix Inc....
BioCentury | Aug 24, 2015
Company News

Ferring, Intralytix deal

...Intralytix will assist Ferring in producing and manufacturing the bacteriophages for use in clinical trials. Intralytix...
...to begin next year. Ferring will have the option to license and market the bacteriophages. Intralytix...
...not disclosed, and Ferring did not respond to inquiries. Ferring Pharmaceuticals A/S , Saint-Prex, Switzerland Intralytix Inc....
BioCentury | Aug 15, 2013
Cover Story

B cell lymphoma and the microbiome

...can be freeze-dried and turned into pills without losing efficiency, and phage-based products such as Intralytix Inc....
...monocytogenes . SalmoFresh is a blend of phages that target and kill Salmonella enterica . Intralytix...
...Lou, K.-J. SciBX 6 (31); doi:10.1038/scibx.2013.812 Published online Aug. 15, 2013 Companies and Institutions Mentioned Intralytix Inc....
BioCentury | Sep 26, 2011
Company News

Intralytix, P&G deal

...The companies partnered to develop bacteriophage-based technology for multiple undisclosed applications. Details were not disclosed. Intralytix...
...monocytogenes on food products and EcoShield to reduce or eliminate Escherichia coli on red meat. Intralytix Inc....
Items per page:
1 - 7 of 7